연구성과로 돌아가기
2023 연구자 정보 (69 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Yamashita, Toshinari (Yamashita, T) |
|
|
[JCR상위 1.7] Trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low, hormone receptor-positive (HR plus ) unresectable and/or metastatic breast cancer (mBC): Exploratory biomarker analysis of DESTINY-Breast04 | SCIE | 1.7 | ONCOLOGY | ||||
|
Yang, Sung Woong (Yang, SW) |
Kyungpook Natl Univ KNU, Sch Mat Sci & Engn, Daegu 41566, South Korea Kyungpook Natl Univ, Sch Mat Sci & Engn, Daegu 41566, South Korea Kyungpook Natl Univ, Sch Mat Sci & Engn, Daegu, South Korea |
|
|
[JCR상위 1.7] High-performance self-powered color filter-free blue photodetector based on wide-bandgap halide perovskites [JCR상위 3.9] Ternary diagrams of phase, stability, and optical properties of cesium lead mixed-halide perovskites [JCR상위 3.8] Regulating Surface Heterogeneity Maximizes Photovoltage and Operational Stability in Tin-Lead Perovskite Solar Cells [JCR상위 3.1] High-throughput compositional mapping of triple-cation tin-lead perovskites for high-efficiency solar cells |
SCIE | 1.7 |
MATERIALS SCIENCE, MULTIDISCIPLINARY;METALLURGY & METALLURGICAL ENGINEERING CHEMISTRY, PHYSICAL;ELECTROCHEMISTRY;ENERGY & FUELS;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY MATERIALS SCIENCE, MULTIDISCIPLINARY |
wook2@knu.ac.kr; donghoekim@korea.ac.kr;wook2@knu.ac.kr; |
||
|
Yang, Won Jun (Yang, WJ) |
|
|
[JCR상위 1.7] Incidence, landscape and survival outcome of de novo malignancy after double lung transplantation. [JCR상위 1.7] Machine learning models based on radiomics features to predict treatment response, biomarker status, and bone metastasis in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) |
SCIE | 1.7 | ONCOLOGY | ||||
|
Yared, Jean (Yared, J) |
|
|
[JCR상위 1.7] Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | SCIE | 1.7 | ONCOLOGY | dmiklos@stanford.edu; | |||
|
Yeh, Ta-Sen (Yeh, TS) |
|
|
[JCR상위 1.7] ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Yi, Kiyoun (Yi, K) |
Pusan Natl Univ Hosp, Busan, South Korea |
|
|
[JCR상위 1.7] Real-world experience of atezolizumab plus bevacizumab combination treatment in high risk patients with advanced hepatocellular carcinoma | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | jheo@pusan.ac.kr; | ||
|
Yi, Min (Yi, M) |
Arrowhead Pharmaceut Inc, Pasadena, CA USA |
|
|
[JCR상위 1.7] A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Yoo, Changhoon (Yoo, C) |
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea |
|
|
[JCR상위 1.7] Serum vitamin D3 levels and overall survival (OS) in patients (pts) with advanced biliary tract cancer (BTC): Analysis of the NIFTY trial cohort. [JCR상위 3.6] Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer The Phase 2b NIFTY Randomized Clinical Trial [JCR상위 28.4] Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group (vol 54, pg 1, 2022) |
SCIE | 1.7 | ONCOLOGY | yooc@amc.seoul.kr; | ||
|
Yoo, Tae-Kyung (Yoo, TK) |
|
|
[JCR상위 1.7] Prospective single-arm study of endocrine therapies with ovarian function suppression in premenopausal patients with node-positive early breast cancer with low genomic risk (INTERSTELLAR trial, KBCSG-25) [JCR상위 1.7] Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial) |
SCIE | 1.7 | ONCOLOGY | ||||
|
Yoon, Chang Ik (Yoon, CI) |
IAP-6721-2023 Kim, Chang Gon |
|
[JCR상위 1.7] Prospective single-arm study of endocrine therapies with ovarian function suppression in premenopausal patients with node-positive early breast cancer with low genomic risk (INTERSTELLAR trial, KBCSG-25) | SCIE | 1.7 | ONCOLOGY | ||||
|
Yoon, Eileen (Yoon, E) |
Hanyang Univ, Coll Med, Seoul, South Korea |
|
|
[JCR상위 1.7] The role of M2BPGi in screening for advanced hepatic fibrosis in diabetic patients [JCR상위 1.7] The role of M2BPGi for screening of advanced hepatic fibrosis in elderly patients [JCR상위 1.7] Fibrosis-4 and M2BPGi combination screening algorithm for screening advanced hepatic fibrosis in diabetes is cost-effective |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | noshin@hanyang.ac.kr; | ||
|
Yoon, Sung Mi (Yoon, SM) |
|
|
[JCR상위 1.7] Machine learning models based on radiomics features to predict treatment response, biomarker status, and bone metastasis in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) | SCIE | 1.7 | ONCOLOGY | ||||
|
Youn, Hyun Jo (Youn, HJ) |
|
|
[JCR상위 1.7] Prospective single-arm study of endocrine therapies with ovarian function suppression in premenopausal patients with node-positive early breast cancer with low genomic risk (INTERSTELLAR trial, KBCSG-25) [JCR상위 1.7] Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial) |
SCIE | 1.7 | ONCOLOGY | ||||
|
Youssoufian, Hagop (Youssoufian, H) |
|
|
[JCR상위 1.7] Phase 2 study of bavituximab (bavi), a first-in-class antibody targeting phosphatidylserine (PS), plus pembrolizumab (P) in advanced gastric or gastroesophageal junction (GEJ) cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Yu, Jisang (Yu, J) |
Northwestern Univ, Feinberg Sch Med, Chicago, IL 60208 USA Northwestern Mem Hosp, Dept Internal Med, Chicago, IL 60611 USA |
|
0000-0002-4370-947X Yu, Jisang |
[JCR상위 1.7] Post-double lung transplantation survival outcomes of bilateral lung cancer and incidence of post-transplant lung cancer [JCR상위 1.7] Incidence, landscape and survival outcome of de novo malignancy after double lung transplantation. [JCR상위 67.0] Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer [JCR상위 19.0] A Comprehensive Landscape of De Novo Malignancy After Double Lung Transplantation [JCR상위 1.7] Machine learning models based on radiomics features to predict treatment response, biomarker status, and bone metastasis in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) |
SCIE | 1.7 |
ONCOLOGY SURGERY;TRANSPLANTATION |
ankit.bharat@nm.org;ychae@nm.org; ychae@nm.org; |
페이지 이동: